Rare diseases
Investigational molecules
Locations
Back to Italy2 clinical trials in Eboli, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of felzartamab compared to placebo in adults with IgA nephropathy
ItalyStudy on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on IgA nephropathy (IgAN), a significant kidney condition, are exploring innovative therapeutic approaches. These trials aim to evaluate targeted treatments based on kidney biopsy findings.
The research examines the effectiveness of early corticosteroid therapy and SGLT2 inhibitors in combination with standard treatments, seeking to optimize patient outcomes while minimizing potential side effects.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
